Concepedia

Kathy Robie‐Suh

KR

Statistics

Publications

5

Citations

295

H-Index

5

Active since

2006

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Kathy Robie‐Suh is an author at Center for Drug Evaluation and Research specializing in pharmacology, clinical pharmacology, and medicine.

Publications per year

2006–2012

5

Publications

5

FDA Report: Eculizumab (Soliris®) for the Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria

Andrew Dmytrijuk, Kathy Robie‐Suh, Martin H. Cohen et al. · The Oncologist · 2008 · 136 citations · Full text

, , +9

Utility of a physiologically–based pharmacokinetic (PBPK) modeling approach to quantitatively predict a complex drug–drug–disease interaction scenario for rivaroxaban during the drug review process: implications for clinical practice

Joseph A. Grillo, Ping Zhao, Julie Bullock et al. · Biopharmaceutics & Drug Disposition · 2012 · 93 citations

, , +17

Deferasirox for the treatment of chronic iron overload in transfusional hemosiderosis.

George G. Shashaty, Raymond Frankewich, Tamal Chakraborti et al. · PubMed · 2006 · 24 citations

, , +17

Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura.

Faranak Jamali, Steven J. Lemery, Kassa Ayalew et al. · PubMed · 2009 · 21 citations

, , +6

Eltrombopag for the treatment of chronic immune (idiopathic) thrombocytopenic purpura.

Andrew Dmytrijuk, Kathy Robie‐Suh, Dwaine Rieves et al. · PubMed · 2009 · 21 citations

, , +7

1–5 of 5